{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:26:10Z","timestamp":1792110370056,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004028","name":"Jiangnan University","doi-asserted-by":"publisher","award":["1285081903200020"],"award-info":[{"award-number":["1285081903200020"]}],"id":[{"id":"10.13039\/501100004028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301581"],"award-info":[{"award-number":["82301581"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurot.2025.e00739","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:42:09Z","timestamp":1757655729000},"page":"e00739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeted ErbB4 receptor activation ameliorates neuronal deficits via DOCK3 signaling in a transgenic mouse AD model"],"prefix":"10.1016","volume":"22","author":[{"given":"Chong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-ji","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ke","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-meng","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-qin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-jiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2025.e00739_bib1","unstructured":"World Alzheimer's report 2023: reducing dementia risk: never too early, never too late."},{"key":"10.1016\/j.neurot.2025.e00739_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer's disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00739_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00739_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00739_bib5","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1172\/JCI137040","article-title":"Tau is not necessary for amyloid-\u03b2-induced synaptic and memory impairments","volume":"130","author":"Puzzo","year":"2020","journal-title":"J Clin Investig"},{"issue":"10284","key":"10.1016\/j.neurot.2025.e00739_bib6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00739_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7861\/clinmedicine.16-3-247","article-title":"Drug treatments in Alzheimer's disease","volume":"16","author":"Briggs","year":"2016","journal-title":"Clin Med"},{"key":"10.1016\/j.neurot.2025.e00739_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.662474","article-title":"Neuregulins in neurodegenerative diseases","volume":"13","author":"Ou","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00739_bib9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5115\/acb.2010.43.4.332","article-title":"Expression of ErbB4 in the apoptotic neurons of Alzheimer's disease brain","volume":"43","author":"Woo","year":"2010","journal-title":"Anatomy Cell Bio"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00739_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5115\/acb.2011.44.2.116","article-title":"Expression of ErbB4 in the neurons of Alzheimer's disease brain and APP\/PS1 mice, a model of Alzheimer's disease","volume":"44","author":"Woo","year":"2011","journal-title":"Anatomy Cell Bio"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00739_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020698","article-title":"Inhibitory neural network's impairments at hippocampal CA1 LTP in an aged transgenic mouse model of Alzheimer's Disease","volume":"22","author":"Seo","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.neurot.2025.e00739_bib12","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1002\/cne.25207","article-title":"ErbB4 mediates amyloid \u03b2-induced neurotoxicity through JNK\/tau pathway activation: implications for Alzheimer's disease","volume":"529","author":"Zhang","year":"2021","journal-title":"J Comp Neurol"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00739_bib13","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2174\/1570159X20666220830105350","article-title":"Virtual screening-based drug development for the treatment of nervous system diseases","volume":"21","author":"Li","year":"2023","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.neurot.2025.e00739_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1528604","article-title":"Targeted ErbB4 receptor activation prevents D-Galactose-induced neuronal senescence via inhibiting ferroptosis pathway","volume":"16","author":"Dao","year":"2025","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00739_bib15","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300386RR","article-title":"DOCK3 regulates normal skeletal muscle regeneration and glucose metabolism","volume":"37","author":"Samani","year":"2023","journal-title":"FASEB J: Offic Public Federation Am Soc Exper Biol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00739_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1471-4159.2000.0750109.x","article-title":"Isolation and characterization of novel presenilin binding protein","volume":"75","author":"Kashiwa","year":"2000","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00739_bib17","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0002-9440(10)63005-2","article-title":"Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation","volume":"159","author":"Chen","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neurot.2025.e00739_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.06.005","article-title":"Dock GEFs and their therapeutic potential: neuroprotection and axon regeneration","volume":"43","author":"Namekata","year":"2014","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.neurot.2025.e00739_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1756-6606-6-22","article-title":"Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity","volume":"6","author":"Bai","year":"2013","journal-title":"Mol Brain"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00739_bib20","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1111\/ejn.13442","article-title":"Human tau increases amyloid \u03b2 plaque size but not amyloid \u03b2-mediated synapse loss in a novel mouse model of Alzheimer's disease","volume":"44","author":"Jackson","year":"2016","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00739_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1074\/mcp.R115.053330","article-title":"Neurodegeneration and Alzheimer's disease (AD). What can proteomics tell us about the alzheimer's brain?","volume":"15","author":"Moya-Alvarado","year":"2016","journal-title":"Mol Cell Proteomics : MCP"},{"key":"10.1016\/j.neurot.2025.e00739_bib22","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.biopha.2017.11.039","article-title":"Andrographolide sulfonate improves Alzheimer-associated phenotypes and mitochondrial dysfunction in APP\/PS1 transgenic mice","volume":"97","author":"Geng","year":"2018","journal-title":"Biomed Pharma Biom Pharma"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00739_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113280","article-title":"SIRT3-mediated deacetylation protects inner hair cell synapses in a H(2)O(2)-induced oxidative stress model in vitro","volume":"418","author":"Zhao","year":"2022","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.neurot.2025.e00739_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5567174","article-title":"ROS-induced oxidative damage and mitochondrial dysfunction mediated by inhibition of SIRT3 in cultured cochlear cells","volume":"2022","author":"Zhang","year":"2022","journal-title":"Neural Plast"},{"key":"10.1016\/j.neurot.2025.e00739_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106722","article-title":"Inhibition of miR-134-5p protects against kainic acid-induced excitotoxicity through Sirt3-mediated preservation of mitochondrial function","volume":"176","author":"Lin","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neurot.2025.e00739_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-024-04013-w","article-title":"Tirzepatide administration improves cognitive impairment in HFD mice by regulating the SIRT3-NLRP3 axis","author":"Ma","year":"2024","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00739_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12974-025-03406-6","article-title":"Targeted activation of ErbB4 receptor ameliorates neuronal deficits and neuroinflammation in a food-borne polystyrene microplastic exposed mouse model","volume":"22","author":"Liu","year":"2025","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurot.2025.e00739_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jns.2004.11.040","article-title":"Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease","volume":"229\u2013230","author":"Aliyev","year":"2005","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00739_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-5223(19)37950-4","article-title":"Ultrastructural and cytochemical correlates of myocardial protection by cardiac hypothermia in man","volume":"79","author":"Flameng","year":"1980","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00739_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1582-4934.2008.00324.x","article-title":"Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats","volume":"13","author":"Aliev","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00739_bib31","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1600-6143.2004.00448.x","article-title":"Ultrastructural changes of rat cardiac myocytes in a time-dependent manner after traumatic brain injury","volume":"4","author":"Ozisik","year":"2004","journal-title":"Am J Transplant : official journal of the American Society of Transplantation and the Am Soc Transp Surg"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00739_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/BJ20100993","article-title":"MOCA is an integrator of the neuronal death signals that are activated by familial Alzheimer's disease-related mutants of amyloid \u03b2 precursor protein and presenilins","volume":"442","author":"Tachi","year":"2012","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00739_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1083\/jcb.200110151","article-title":"A novel mechanism for the regulation of amyloid precursor protein metabolism","volume":"158","author":"Chen","year":"2002","journal-title":"J Cell Biol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00739_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.30","article-title":"Neuregulin-1 attenuates cognitive function impairments in a transgenic mouse model of Alzheimer's disease","volume":"7","author":"Ryu","year":"2016","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00739_bib35","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1007\/s12035-016-9956-5","article-title":"Down-Regulation of Neuregulin1\/ErbB4 signaling in the hippocampus is critical for learning and memory","volume":"54","author":"Tian","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neurot.2025.e00739_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/srep29152","article-title":"The reemergence of long-term potentiation in aged Alzheimer's disease mouse model","volume":"6","author":"Huh","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00739_bib37","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/jnc.13026","article-title":"Systemically administered neuregulin-1\u03b21 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease","volume":"133","author":"Depboylu","year":"2015","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurot.2025.e00739_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1623050","article-title":"Elucidating molecular pathogenesis and developing targeted therapeutic interventions for cerebrovascular endothelial cell-mediated vascular dementia","volume":"17","author":"Yang","year":"2025","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00739_bib39","first-page":"215","article-title":"Dock3-NMDA receptor interaction as a target for glaucoma therapy","volume":"32","author":"Kimura","year":"2017","journal-title":"Histol Histopathol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00739_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ajmg.a.38517","article-title":"DOCK3-related neurodevelopmental syndrome: biallelic intragenic deletion of DOCK3 in a boy with developmental delay and hypotonia","volume":"176","author":"Iwata-Otsubo","year":"2018","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00739_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yexcr.2017.03.044","article-title":"The drosophila DOCK family protein sponge is required for development of the air sac primordium","volume":"354","author":"Morishita","year":"2017","journal-title":"Exp Cell Res"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00739_bib42","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/cge.12995","article-title":"Biallelic loss-of-function variants in DOCK3 cause muscle hypotonia, ataxia, and intellectual disability","volume":"92","author":"Helbig","year":"2017","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00739_bib43","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1007\/s12035-015-9406-9","article-title":"Dock3 participate in epileptogenesis through rac1 pathway in animal models","volume":"53","author":"Li","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00739_bib44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cmet.2015.10.013","article-title":"Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges","volume":"23","author":"Cheng","year":"2016","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00739_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2047-9158-2-12","article-title":"Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration","volume":"2","author":"McInnes","year":"2013","journal-title":"Transl Neurodegener"},{"issue":"6512","key":"10.1016\/j.neurot.2025.e00739_bib46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.abb8587","article-title":"Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases","volume":"370","author":"Bartels","year":"2020","journal-title":"Science (New York, NY)"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00739_bib47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00739_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00739_bib49","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat Neurosci"},{"issue":"16","key":"10.1016\/j.neurot.2025.e00739_bib50","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.neuron.2024.07.016","article-title":"Microglia's heroic battle against neurodegeneration","volume":"112","author":"Kattimani","year":"2024","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00739_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/biology10100948","article-title":"Neuron-derived extracellular vesicles modulate microglia activation and function","volume":"10","author":"Peng","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.neurot.2025.e00739_bib52","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat Commun"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792500217X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792500217X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:46:18Z","timestamp":1772894778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792500217X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S187874792500217X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00739","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted ErbB4 receptor activation ameliorates neuronal deficits via DOCK3 signaling in a transgenic mouse AD model","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00739"}}